title: Thioredoxin-interacting protein and chronic lymphocytic leukemia.
authors.forename: E
authors.initials: E
authors.lastname: Friday
authors.forename: N
authors.initials: N
authors.lastname: Koshy
authors.forename: V
authors.initials: V
authors.lastname: Bhanderi
authors.forename: F
authors.initials: F
authors.lastname: Turturro
mesh_terms: D000368:Aged; D000375:Aging / Q000378:metabolism; D000818:Animals; D002352:Carrier Proteins / Q000096:biosynthesis* / Q000235:genetics; D018450:Disease Progression; D005260:Female; D015973:Gene Expression Regulation, Leukemic; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics / Q000378:metabolism*; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000096:biosynthesis* / Q000235:genetics; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D012334:RNA, Neoplasm / Q000096:biosynthesis / Q000235:genetics; D017382:Reactive Oxygen Species / Q000378:metabolism; D015854:Up-Regulation
chemical_list: D002352:Carrier Proteins; D009363:Neoplasm Proteins; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D017382:Reactive Oxygen Species; C486715:TXNIP protein, human